XNAS: FULC
Fulcrum Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases. Its product candidate, Pociredir, is an oral small molecule designed to induce fetal hemoglobin (HbF) ...
Read More
3.62
-0.03
(-0.82%)
822.2K
XNAS Volume
XNAS 20 Jul, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Fulcrum Therapeutics Inc is on 29 Jul 2026 for the purpose of Fulcrum Therapeutics Inc Second Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Bearish
Fulcrum Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..